Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald M. Miller

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Journal of Cancer Research and Clinical Oncology|June 3, 2006
A phase II study of extended dose temozolomide and thalidomide in previously treated patients with metastatic melanomaDamian A Laber, Roseline I Okeke, Carlos Arce-Lara, et al.
Lung Cancer (Amsterdam, Netherlands)|April 21, 2021
Evaluation of disease staging and chemotherapeutic response in non-small cell lung cancer from patient tumor-derived metabolomic dataHunter A Miller, Xinmin Yin, Susan A Smith, et al.
Journal of Translational Medicine|March 13, 2008
Transient T cell depletion causes regression of melanoma metastasesMary Ann Rasku, Amy L Clem, Sucheta Telang, et al.
Nature Communications|February 18, 2017
MVP-mediated exosomal sorting of miR-193a promotes colon cancer progressionYun Teng, Yi Ren, Xin Hu, et al.
Current Oncology (Toronto, Ont.)|March 27, 2024
Spatially Resolved Microglia/Macrophages in Recurrent Glioblastomas Overexpress Fatty Acid Metabolism and Phagocytic GenesAkshitkumar M Mistry, Jonah Daneshmand, SeonYeong Jamie Seo, et al.
Molecular Cancer Therapeutics|May 16, 2013
Targeting 6-phosphofructo-2-kinase (PFKFB3) as a therapeutic strategy against cancerBrian F Clem, Julie O'Neal, Gilles Tapolsky, et al.
The Journal of Clinical Investigation|January 22, 2015
Pyruvate carboxylase is critical for non-small-cell lung cancer proliferationKatherine Sellers, Matthew P Fox, Michael Bousamra, et al.
Experimental Cell Research|July 25, 2003
Inhibition of tumorigenicity by the 5'-untranslated RNA of the human c-myc P0 transcriptScott W Blume, Donald M Miller, Vincenzo Guarcello, et al.
Oncotarget|June 4, 2016
MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signalingJino Park, Soojin Kim, Joongho Joh, et al.
BMC Cancer|December 15, 2011
Phase II trial of the regulatory T cell-depleting agent, denileukin diftitox, in patients with unresectable stage IV melanomaSucheta Telang, Mary Ann Rasku, Amy L Clem, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Journal of Cancer Research and Clinical Oncology|June 3, 2006
A phase II study of extended dose temozolomide and thalidomide in previously treated patients with metastatic melanomaDamian A Laber, Roseline I Okeke, Carlos Arce-Lara, et al.
Lung Cancer (Amsterdam, Netherlands)|April 21, 2021
Evaluation of disease staging and chemotherapeutic response in non-small cell lung cancer from patient tumor-derived metabolomic dataHunter A Miller, Xinmin Yin, Susan A Smith, et al.
Journal of Translational Medicine|March 13, 2008
Transient T cell depletion causes regression of melanoma metastasesMary Ann Rasku, Amy L Clem, Sucheta Telang, et al.
Nature Communications|February 18, 2017
MVP-mediated exosomal sorting of miR-193a promotes colon cancer progressionYun Teng, Yi Ren, Xin Hu, et al.
Current Oncology (Toronto, Ont.)|March 27, 2024
Spatially Resolved Microglia/Macrophages in Recurrent Glioblastomas Overexpress Fatty Acid Metabolism and Phagocytic GenesAkshitkumar M Mistry, Jonah Daneshmand, SeonYeong Jamie Seo, et al.
Molecular Cancer Therapeutics|May 16, 2013
Targeting 6-phosphofructo-2-kinase (PFKFB3) as a therapeutic strategy against cancerBrian F Clem, Julie O'Neal, Gilles Tapolsky, et al.
The Journal of Clinical Investigation|January 22, 2015
Pyruvate carboxylase is critical for non-small-cell lung cancer proliferationKatherine Sellers, Matthew P Fox, Michael Bousamra, et al.
Experimental Cell Research|July 25, 2003
Inhibition of tumorigenicity by the 5'-untranslated RNA of the human c-myc P0 transcriptScott W Blume, Donald M Miller, Vincenzo Guarcello, et al.
Oncotarget|June 4, 2016
MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signalingJino Park, Soojin Kim, Joongho Joh, et al.
BMC Cancer|December 15, 2011
Phase II trial of the regulatory T cell-depleting agent, denileukin diftitox, in patients with unresectable stage IV melanomaSucheta Telang, Mary Ann Rasku, Amy L Clem, et al.
Pageof 7